41.   That, along with several other failures of high-profile biotech drugs this year, contributed to a protracted decline in all biotech stocks.

42.   The announcement fueled drops in other leading U.K. biotech stocks as investors were reminded of the risks in biotechnology.

43.   The cancer meeting was supposed to have given biotech stocks a lift to carry them through the summer doldrums.

44.   The average biotech stock, in fact, is trading below where it was five years ago.

45.   The conventional wisdom making the rounds was that the era of hype-driven biotech stocks has ended.

46.   The firm quickly became a leading backer of biotech stocks, with a reputation for bringing out share offerings of many new companies, even in adverse markets.

47.   The drug failures are not the only thing hurting biotech stocks.

48.   The fund includes a mix of pharmaceutical, medical device and analytical equipment, healthcare services, and biotech stocks.

49.   The money had been flowing to the sector because of its hot performance, further inflating the price of biotech stocks.

50.   Their pronouncement spooked Wall Street into thinking the government might ban gene patents, sparked a run on biotech stocks and wiped out billions of dollars of paper wealth.